Drexel, MO – According to filings with the U.S. Securities and Exchange Commission, Innovaprep is raising $3,001,136.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Alburty played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Innovaprep
InnovaPrep is engaged in product development, manufacturing, sales, service, and related out-licensing of a collection of novel technologies enabling rapid detection of biological particles and pathogens. Our core business is biological sample collection, concentration and preparation. The company has commercialized a collection of market-disruptive platform technologies for rapid, automated concentration of biological particles. InnovaPreps 35 pending and awarded patents apply to highly efficient collection, recovery, and concentration of biological particles from air, surfaces, and liquids. Our elution process underlies many of these patents and enables recovery of particles from filters, membranes, surfaces, and objects. The primary utility for these technologies is to greatly improve the way biological samples, especially those containing pathogenic organisms, are collected and prepared for analysis beyond the state-of-the-art.

To learn more about Innovaprep, visit http://www.innovaprep.com/

Contact:
David Alburty, Chief Executive Officer
816-619-3375
dalburty@innovaprep.com
https://www.linkedin.com/in/dave-alburty-627a921/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved